Table of Contents
ISRN Oncology
Volume 2012, Article ID 278093, 23 pages
http://dx.doi.org/10.5402/2012/278093
Review Article

Immunotherapy of Malignant Disease Using Chimeric Antigen Receptor Engrafted T Cells

John Maher1,2,3

1CAR Mechanics Group, Department of Research Oncology, King’s Health Partners Integrated Cancer Centre, King’s College London, Guy’s Hospital Campus, Great Maze Pond, London SE1 9RT, UK
2Department of Immunology, Barnet and Chase Farm Hospitals NHS Trust, Barnet, Hertfordshire EN5 3DJ, UK
3Department of Clinical Immunology and Allergy, King’s College Hospital NHS Foundation Trust, Denmark Hill, London SE5 9RS, UK

Received 23 October 2012; Accepted 14 November 2012

Academic Editors: D. E. Bassi and J. Tovari

Copyright © 2012 John Maher. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

John Maher, “Immunotherapy of Malignant Disease Using Chimeric Antigen Receptor Engrafted T Cells,” ISRN Oncology, vol. 2012, Article ID 278093, 23 pages, 2012. https://doi.org/10.5402/2012/278093.